Polymerized laminin-modified microcapsules improve pancreatic islet resilience towards cytokine induced inflammatory stress and lower chemoattractant cytokine secretion

Polymerized laminin-modified microcapsules improve pancreatic islet resilience towards cytokine induced inflammatory stress and lower chemoattractant cytokine secretion

Encapsulation of human pancreatic islets in semipermeable membranes offers a promising, less invasive alternative to whole pancreas transplantation for Type 1 Diabetes (T1D), potentially reducing the need for immunosuppressive drugs and improving graft survival. However, the inflammatory environment...

Full description

Saved in:
Bibliographic Details
Main Authors: Isaura Beatriz Borges Silva, Theo Borghuis, Tian Qin, Mari Cleide Sogayar, Paul de Vos
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Materials Today Bio
Subjects:
Encapsulation
Type 1 Diabetes
Extracellular matrix
Islet transplantation
Laminin
Online Access:http://www.sciencedirect.com/science/article/pii/S2590006425003722
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Encapsulation of human pancreatic islets in semipermeable membranes offers a promising, less invasive alternative to whole pancreas transplantation for Type 1 Diabetes (T1D), potentially reducing the need for immunosuppressive drugs and improving graft survival. However, the inflammatory environment during transplantation poses significant challenges, often leading to substantial graft loss. This study explores modifying the intracapsular environment with extracellular matrix (ECM) molecules – chondroitin sulfate (ChS), laminin (LN), and polymerized laminin (pLN) – to enhance islet cell resilience against cytokine-induced stress, associated with the post-transplantation environment. Encapsulated mouse insulinoma β-cells (MIN6) and human islets were exposed to pro-inflammatory cytokines (IL-1β, IFN-γ, TNF-α) over 1, 3, and 5 days. The results showed that LN and pLN in combination with ChS particularly improved outcomes, with LN reducing oxidative stress and pLN significantly lowering cell death and pro-inflammatory chemokine MCP-1 production. These findings highlight the potential of ECM-modified encapsulation to enhance the survival of transplanted islets, offering a more favorable approach for T1D treatment and allowing transplantation of pancreatic islets with fewer islets.
ISSN:2590-0064

Similar Items